In some it is: Median time from disease to progression to end stage kidney disease is 2.7 years after 5 years 37% of patients with lcdd are alive with no end stage renal disease autologous stem cell is being used in some patients, but the studies are very limited high dose Melphalan therapy with stem cell transplatation has been used as well, and is considered as treatment of choice by some.
Answered 5/18/2016
5.4k views
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question